Home > Cashflow Statement > NATCO PHARMA

NATCO PHARMA
Cash Flow from Operating Activities

    Back to Cashflow Statement
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Operating Activities ₹1,697 Cr₹1,212 Cr₹849 Cr₹47 Cr₹299 Cr

What is the latest Cash Flow from Operating Activities ratio of NATCO PHARMA ?

The latest Cash Flow from Operating Activities ratio of NATCO PHARMA is ₹1,697 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Operating Activities
Mar2025₹1,697 Cr
Mar2024₹1,212 Cr
Mar2023₹849 Cr
Mar2022₹47 Cr
Mar2021₹299 Cr

How is Cash Flow from Operating Activities of NATCO PHARMA Trending?

Years Cash Flow from Operating Activities % Change
Mar2025 ₹1,697 Cr
40.05
Mar2024 ₹1,212 Cr
42.69
Mar2023 ₹849 Cr
1,726.02
Mar2022 ₹47 Cr
-84.44
Mar2021 ₹299 Cr -

Compare Cash Flow from Operating Activities of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹16,456.6 Cr 1.7% -23.9% 1.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹449,299.0 Cr 1.4% 1.2% 13.8% Stock Analytics
DIVIS LABORATORIES ₹174,207.0 Cr -0.5% -0.6% 4% Stock Analytics
TORRENT PHARMACEUTICALS ₹157,721.0 Cr 2.1% 1.5% 42.2% Stock Analytics
CIPLA ₹117,420.0 Cr 6.4% 1.6% -3.1% Stock Analytics
DR REDDYS LABORATORIES ₹114,876.0 Cr 6.2% 1.6% 0.2% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

1.7%

-23.9%

1.4%

SENSEX

-0.1%

1%

-5.7%


You may also like the below Video Courses